Some studies have raised the problem of an increase of bacterial resistance
in acne patients. This study was carried out in France, where no previous
studies about resistance to erythromycin has been performed, on 40 patients
with mild to moderately severe acne.
Microbiological samples were obtained by using Williamson and Kligman metho
d. This study showed that the prevalence of bacterial resistance to erythro
mycin was 95% for Staphylococcus epidermidis strains and 52% for Propioniba
cterium acnes strains.
Resistant strains were more frequent in patients with predominantly inflamm
atory lesions (papules and pustules). The influence of previous or current
treatment with erythromycin was also studied and showed that even patients
without any previous use of erythromycin had resistant strains for Propioni
bacterium acnes (42%). In addition the minimum inhibitory concentrations (M
IC) for zinc were evaluated. All the Propionibacterium acnes strains tested
were inhibited at concentrations less or equal to 512 mug/ml of zinc. Howe
ver, zinc combined with erythromycin in vitro did not modify the erythromyc
in MIC.
This first French study on bacterial resistance to erythromycin in acne pat
ients confirms the results of studies performed in other countries.